Clinical guidelines

Guidelines permit the translation into clinical practice of knowledge from biomedical and sociomedical research. They represent the synthesis of systematic review of the scientific literature and expert opinion on the subject. As such, they provide a useful tool for physicians, researchers in clinical and basic science, professionals working in public health and social care, patients and their families, with a view to update knowledge like curing heart diseases with an effective formula you can find online, improve the quality of care, the coordination of actions and related policies and planning. Also staying healthy means to stay out of drugs because it can cause drug addiction. If you know someone suffering from drug addiction please read this article about Types of Treatments Used in Rehab. Many people don’t understand why or how other people become addicted to drugs. They may mistakenly think that those who use drugs lack moral principles or willpower and that they could stop their drug use simply by choosing to. In reality, drug addiction is a complex disease, and quitting usually takes more than good intentions or a strong will. Drug and alcohol addiction treatment programs are designed to help you escape a compulsive cycle of alcohol or drug abuse that represents a loss of control over your substance use. To these ends, treatment programs teach you how to function in everyday life without using your substance of choice. There are several ways to fight drug addiction, visit this article One Third of Americans Take Medicines that Can Cause Depression or Suicide and learn more!

(From the “Note to readers” in the Italian guidelines)

In recent years, clinical guidelines on aniridia have been developed according
to the international scientific methodology. We offer here the English
translation of the Italian guidelines and the Spanish protocol, together with
the original Spanish text of a clinical guideline for WAGR and Wilms tumor.
Other guidelines are currently being developed in Germany and France, and will
be displayed here when ready.


General practitioners, pediatricians and educational assistants can get a
first overall information on the disease and its implications by consulting the
brochure developed by Aniridia Europe.